• LAST PRICE
    7.7000
  • TODAY'S CHANGE (%)
    Trending Down-0.5800 (-7.0048%)
  • Bid / Lots
    7.7000/ 2
  • Ask / Lots
    11.2000/ 3
  • Open / Previous Close
    8.2300 / 8.2800
  • Day Range
    Low 7.4100
    High 8.4099
  • 52 Week Range
    Low 6.5001
    High 14.7400
  • Volume
    399,083
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 8.28
TimeVolumeINMB
09:32 ET2708.23
09:34 ET4008.23
09:36 ET10378.23
09:48 ET1008.4099
09:54 ET31868.21
09:59 ET4718.15
10:01 ET6008.09
10:03 ET164358
10:06 ET71447.97
10:08 ET2007.96
10:10 ET2007.97
10:14 ET2757.94
10:15 ET1007.9
10:17 ET29867.99
10:19 ET59537.95
10:21 ET38667.88
10:24 ET14957.865
10:28 ET1387.8
10:30 ET5007.8092
10:32 ET7007.82
10:33 ET3007.82
10:37 ET33567.875
10:39 ET171517.9
10:44 ET4007.88
10:46 ET1007.83
10:50 ET30007.83
10:51 ET1007.83
10:53 ET11007.8
10:55 ET3997.79
10:57 ET15327.817
11:00 ET7007.79
11:06 ET18877.82
11:08 ET2857.81
11:09 ET10007.81
11:13 ET51007.79
11:18 ET1007.795
11:20 ET6017.795
11:24 ET7447.8
11:26 ET20007.79
11:27 ET3007.79
11:29 ET7007.805
11:33 ET16007.8499
11:36 ET12507.825
11:38 ET28007.85
11:40 ET3007.875
11:42 ET1007.86
11:45 ET1007.8783
11:49 ET1007.87
11:51 ET10177.89
11:56 ET88437.89
11:58 ET3007.89
12:00 ET2007.89
12:02 ET1807.9092
12:03 ET5647.9
12:05 ET5007.9
12:07 ET102007.87
12:09 ET7607.87
12:12 ET5687.89
12:14 ET5007.9002
12:18 ET7007.88
12:20 ET5007.8824
12:21 ET5007.84
12:23 ET9657.81
12:25 ET37207.8
12:27 ET7007.815
12:30 ET7007.8
12:32 ET58297.71
12:36 ET118527.62
12:38 ET19017.57
12:39 ET32827.595
12:43 ET70967.48
12:45 ET4607.445
12:48 ET22007.445
12:50 ET11007.45
12:52 ET14347.45
12:54 ET73387.4675
12:57 ET73767.545
12:59 ET13007.545
01:01 ET4007.5101
01:06 ET21037.52
01:08 ET1007.56
01:10 ET69927.575
01:12 ET37977.68
01:14 ET22497.73
01:17 ET2897.75
01:19 ET124867.77
01:21 ET23157.775
01:24 ET5607.775
01:26 ET104097.94
01:28 ET32007.8904
01:30 ET10897.89
01:32 ET6007.79
01:37 ET1007.82
01:42 ET7197.78
01:44 ET36367.8
01:46 ET33627.78
01:48 ET1007.75
01:53 ET2007.745
01:57 ET5007.7201
02:00 ET1007.72
02:04 ET8447.7696
02:06 ET4007.7697
02:08 ET1007.72
02:09 ET14007.73
02:11 ET8317.71
02:13 ET2627.735
02:15 ET1007.71
02:18 ET10627.7589
02:20 ET19007.735
02:24 ET3007.755
02:27 ET1007.735
02:29 ET2607.71
02:38 ET51007.79
02:42 ET79907.75
02:45 ET1007.71
02:47 ET1007.71
02:49 ET11037.71
02:51 ET34137.66
02:54 ET80297.645
02:56 ET1007.62
02:58 ET2007.645
03:00 ET2007.64
03:03 ET9507.6288
03:05 ET16507.61
03:07 ET6007.624
03:09 ET16007.615
03:12 ET68757.635
03:16 ET6007.64
03:18 ET3507.65
03:20 ET1007.6525
03:21 ET32107.57
03:23 ET83377.5807
03:27 ET42007.55
03:30 ET6007.52
03:32 ET1007.51
03:34 ET102167.5611
03:36 ET49777.58
03:38 ET29507.58
03:39 ET32977.645
03:41 ET7517.63
03:43 ET4007.62
03:45 ET29177.655
03:48 ET75047.7
03:50 ET11907.71
03:52 ET20007.705
03:54 ET10347.71
03:56 ET24457.705
03:57 ET4007.71
03:59 ET23597.7
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesINMB
INmune Bio Inc
152.3M
-4.0x
---
United StatesCNTX
Context Therapeutics Inc
151.5M
-1.5x
---
United StatesELEV
Elevation Oncology Inc
150.8M
-2.7x
---
United StatesCMPX
Compass Therapeutics Inc.
154.1M
-3.2x
---
United StatesVIGL
Vigil Neuroscience Inc
145.5M
-1.8x
---
United StatesGALT
Galectin Therapeutics Inc
144.8M
-3.2x
---
As of 2024-06-19

Company Information

INmune Bio Inc. is a clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. It has two therapeutic platforms: a Dominant-Negative Tumor Necrosis Factor Platform (DN-TNF, XPro, XPro1595 or pegipanermin) and a Natural Killer (NK or INKmune) platform. The DN-TNF product platform utilizes dominant-negative technology to selectively neutralize soluble TNF, a key driver of innate immune dysfunction and a mechanistic driver of many diseases. DN-TNF product candidates are in clinical trials to determine if they can treat cancer (INB03) Mild Alzheimer's disease, Mild Cognitive Impairment and treatment-resistant depression (XPro). The NK Cell Priming Platform includes INKmune developed to prime a patient's NK cells to eliminate minimal residual disease in patients with cancer. Its product platforms utilize a precision medicine approach for the treatment of hematologic and solid tumor malignancies, and chronic inflammation.

Contact Information

Headquarters
225 Ne Mizner Blvd, Suite 640BOCA RATON, FL, United States 33432
Phone
858-964-3720
Fax
---

Executives

President, Chief Executive Officer, Director
Raymond Tesi
Chief Financial Officer
David Moss
Chief Scientific Officer
Mark Lowdell
Independent Director
Marcia Allen
Independent Director
Edgardo Baracchini

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$152.3M
Revenue (TTM)
$131.0K
Shares Outstanding
19.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.91
EPS
$-1.92
Book Value
$2.12
P/E Ratio
-4.0x
Price/Sales (TTM)
1,162.8
Price/Cash Flow (TTM)
---
Operating Margin
-26,209.92%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.